Equities

Shanghai Runda Medical Technology Co Ltd

603108:SHH

Shanghai Runda Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)19.37
  • Today's Change-0.51 / -2.57%
  • Shares traded43.67m
  • 1 Year change-18.27%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Runda Medical Technology Co., Ltd. is a China-based company, principally engaged in the provision of in-vitro diagnostic devices and professional technique support services for all kinds of medical laboratories. The Company's integrated services include product portfolio options, professional and technical application services, informatization management of logistics warehousing distribution systems and all-round technical support. The Company also provides sales support and customer channel management, among others. The company mainly conducts its businesses within domestic market.

  • Revenue in CNY (TTM)8.43bn
  • Net income in CNY40.27m
  • Incorporated1999
  • Employees3.32k
  • Location
    Shanghai Runda Medical Technology Co Ltd8F, Tower 1, Xinghui Center, No. 89Zhapu Road, Hongkou DistrictSHANGHAI 200085ChinaCHN
  • Phone+86 2 168406213
  • Fax+86 2 168406213
  • Websitehttp://www.rundamedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Microport EP MedTech Co Ltd383.99m35.90m10.08bn577.00280.685.82--26.240.07630.07630.8163.680.20811.307.04665,493.301.95--2.05--57.86--9.35--13.82--0.0109--26.46--85.17------
Shenzhen YHLO Biotech Co Ltd1.90bn288.64m10.39bn1.76k36.253.91--5.460.50260.50263.324.660.48421.074.581,081,307.005.8516.437.4624.1663.9853.2612.0820.011.289.130.247430.28-48.4223.02-64.9356.3228.88--
Qingdao Haier Biomedical Co Ltd2.24bn358.01m11.05bn2.64k30.832.57--4.941.131.137.0413.530.40185.126.38848,473.706.5611.498.2915.2247.8249.9816.3425.202.53--0.031626.53-20.3622.07-32.4128.9420.64--
Shinva Medical Instrument Co Ltd10.12bn692.34m11.11bn8.21k12.961.48--1.101.411.4118.3112.340.67752.204.961,232,589.004.724.639.1410.7625.6224.226.966.120.8303--0.163715.917.87-0.534230.7895.70-5.9061.86
Shandong Weigao Orthopaedic Devce Co Ltd1.28bn154.60m11.55bn2.21k74.832.95--8.990.38580.38583.209.780.25240.67144.03581,131.603.1410.973.9513.6962.4077.3312.4327.083.62--0.009617.90-30.551.17-79.36-19.11-4.31--
Shanghai Runda Medical Technology Co Ltd8.43bn40.27m11.91bn3.32k295.312.77--1.410.06730.067313.617.170.58314.191.492,543,990.001.184.783.1312.8625.9427.132.036.361.013.040.560912.43-12.848.93-34.580.85143.881.03
Beijing Wandong Medical Technolgy Co Ltd1.40bn184.09m12.30bn1.06k66.792.60--8.760.2620.2622.006.740.26472.764.011,325,746.003.505.303.916.2138.8345.2113.2216.469.48--0.017935.8210.305.327.514.22-16.665.39
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.27bn657.34m13.31bn908.0019.853.42--10.505.445.4410.5931.540.3711.336.511,396,816.0019.0017.6821.5519.4374.5176.6051.2142.255.49--0.006744.4632.4338.7237.9840.2850.18--
Sansure Biotech Inc1.41bn259.42m13.73bn2.01k52.671.87--9.760.44750.44752.4412.620.16670.8782.03701,473.702.5226.742.7930.9776.4367.4715.1242.017.45--0.058322.40-84.3927.12-81.22121.8964.08--
Shanghai Haohai Biological Tech Co Ltd2.75bn430.21m13.85bn2.16k35.402.74--5.041.861.8611.8924.070.38331.607.601,272,966.005.604.846.605.5068.9772.0414.6116.363.71--0.069736.8624.5911.24130.580.076211.96--
Micro-Tech Nanjing Co Ltd2.68bn550.49m13.87bn2.40k25.123.72--5.182.942.9414.3019.860.61181.656.801,114,222.0012.8710.7415.2612.8266.0463.0421.0419.373.99--0.018335.4321.7821.2046.9920.3239.33--
Data as of Nov 22 2024. Currency figures normalised to Shanghai Runda Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

2.78%Per cent of shares held by top holders
HolderShares% Held
CCB Principal Asset Management Co., Ltd.as of 30 Jun 20242.89m0.50%
GF Fund Management Co., Ltd.as of 30 Jun 20242.31m0.40%
China Asset Management Co., Ltd.as of 30 Jun 20242.01m0.35%
China Southern Asset Management Co., Ltd.as of 30 Jun 20241.95m0.34%
The Vanguard Group, Inc.as of 06 Nov 20241.68m0.29%
First Seafront Fund Management Co., Ltd.as of 30 Jun 20241.60m0.28%
Penghua Fund Management Co., Ltd.as of 30 Jun 20241.28m0.22%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2024939.40k0.16%
Dimensional Fund Advisors LPas of 07 Nov 2024836.34k0.14%
Wanjia Asset Management Co., Ltd.as of 30 Jun 2024596.30k0.10%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.